Recurrent Acute Pancreatitis Caused by Duodenal Papillary Adenoma: A Case Report and Literature Review
Xianzheng Qin,Chunhua Zhou,Benyan Zhang,Ling Zhang,Tingting Gong,Minmin Zhang,Dong Wang,Duowu Zou
DOI: https://doi.org/10.1111/1751-2980.13160
2023-01-01
Journal of Digestive Diseases
Abstract:To the Editor: Duodenal papillary adenoma is a rare benign gastrointestinal neoplasm with a reported incidence of 0.04%–0.12%. However, it has a malignant potential and usually coexists with duodenal papillary carcinoma. Moreover, duodenal papillary adenoma is insidious in terms of disease onset and is often asymptomatic in the early stage. As the disease progresses, non-specific symptoms such as fever, vomiting, abdominal pain, and jaundice may develop. Although establishing an early diagnosis is difficult, duodenal papillary adenomas have a good treatment response. Here we report a case of recurrent acute pancreatitis caused by duodenal papillary adenoma with features of early malignant transformation to improve the understanding of this rare etiology of recurrent pancreatitis. A 50-year-old man with a history of alcohol abuse for several years presented with severe upper abdominal pain in March 2020 and was admitted to a local hospital. Laboratory evaluation showed elevated serum levels of amylase (778.27 U/L) and lipase (909 U/L). Magnetic resonance cholangiopancreatography (MRCP) revealed pancreatic enlargement, peripancreatic fluid collection, and pancreatic duct dilatation with stones at the pancreatic head (Figure 1A). The patient was considered to have acute pancreatitis. His condition was resolved by conservative managements including fluid resuscitation, bowel rest, antibiotics, and inhibition of pancreatic enzyme secretion. However, 5 months later the patient was readmitted to the hospital due to recurrence of abdominal pain. Laboratory tests showed elevated serum amylase and alkaline phosphatase (ALP) levels, whereas γ-glutamyl transferase (γ-GT) level was within the normal range. Abdominal ultrasonography suggested acute pancreatitis and the patient recovered after 2 weeks of conservative treatment. The patient subsequently visited our hospital for further evaluation in October 2020. He denied flatulence, nausea, vomiting, or fever. Physical examination revealed no significant abnormalities. Laboratory analysis on admission showed that the results of routine blood test, liver function test, and tumor markers were all within normal ranges. Dynamic computed tomography (CT) showed slight pancreatic enlargement with a dilated pancreatic duct in the absence of any radiopaque stones (Figure 1B), which was not consistent with the prior MRCP results. Endoscopic ultrasonography (EUS) revealed a slightly hyperechoic lesion in the main pancreatic duct near the opening of the duodenal papilla, suggesting a pancreatic duct stone (Figure 1C). The patient underwent endoscopic retrograde cholangiopancreatography (ERCP), which showed a filling defect in the head of the pancreas and a slightly dilated pancreatic duct in the body with sparse branch ducts (Figure 2A). Milky pancreatic duct stone fragments and yellowish tissues were observed after balloon traction. The duodenal papillary mucosa at the anal side and yellowish tissues were biopsied for histopathological analysis (Figure 2B,C). A 7-Fr pancreatic plastic stent (5 cm in length) was placed in the main pancreatic duct to prevent post-ERCP pancreatitis (Figure 2D). Histopathological analysis of the biopsy specimen revealed tubulovillous adenoma and adenomatous hyperplasia. Five months after stent placement, the patient was readmitted for surgery. Abdominal CT revealed a dilated pancreatic duct with peripancreatic fluid collection, and MRCP showed slightly dilated main pancreatic duct. Intraductal ultrasonography (IDUS) showed multiple isoechoic lesions at the main pancreatic duct near the duodenal papilla, one of which was 4 mm 4 mm in size, indicating the presence of adenomatous tissues. The lesions were resected under radiographic guidance, with histopathology showing chronic active mucosal inflammation with focal papillary hyperplasia, and lesion of the duodenal papilla was found to be a well-differentiated adenoma. These findings suggested a diagnosis of duodenal adenoma with pancreatic intraductal growth. The patient subsequently underwent robotic pancreaticoduodenectomy on March 17, 2021. There were no intraoperative complications, and he had an uneventful postoperative recovery. Postoperative histopathological examination revealed a duodenal papillary adenoma that was positive for CK7, MUC-1, and MUC5AC, but was negative for CK20, CDX-2, and MUC-2, with high-grade dysplasia and carcinoma in situ in part of the areas (Figure 3). The patient had no recurrence of acute pancreatitis during a 6-month follow-up. Acute pancreatitis is commonly caused by gallstones, alcohol consumption, hypertriglyceridemia, sphincter of Oddi dysfunction, and abnormal anatomy of the biliary tract and pancreatic duct. Furthermore, the pooled prevalence of recurrent acute pancreatitis, characterized by repeated episodes of acute pancreatitis, after the first attack has been reported to be 22%. At least 20% of the cases are described as idiopathic recurrent acute pancreatitis, as initial evaluation fails to clarify the etiology in these cases. Duodenal papillary tumors can cause pancreatic ductal outflow obstruction and are considered causative etiological factors associated with idiopathic recurrent acute pancreatitis. Table 1 summarizes the relevant characteristics of 15 cases of duodenal papillary tumors with acute pancreatitis reported in the Received: 20 January 2022 Revised: 10 February 2023 Accepted: 12 February 2023